Euda Health Holdings Ltd. (EUDA) intrinsic value & 10-year financials
Euda Health Holdings Ltd. (EUDA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 6 fiscal years revenue shrank 10.3% a year to $6.8M, with an average return on invested capital of 199.4%.
- Graham intrinsic value
- —
- Share price (Oct 20, 2026)
- $15.00
- Market cap
- $28.0M
- Revenue (FY2025)
- $6.8M
- Revenue growth (6-yr CAGR)
- -10.3%
- ROIC (10-yr avg)
- 199.4%
- Free cash flow (FY2025)
- -$2.5M
EUDA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $6.8M | -$2.8M | -$1.48 | -$2.5M | -36.3% | 68.2% |
| FY2024 | $4.0M | -$15.4M | -$0.47 | -$2.1M | -432.2% | 334.8% |
| FY2023 | $3.7M | -$10.0M | -$0.44 | — | -106.9% | 178.3% |
| FY2022 | $9.8M | -$24.9M | -$1.03 | -$1.5M | -122.5% | 734.4% |
| FY2021 | $10.5M | $864.8K | $0.04 | $442.0K | -11.6% | -318.9% |
| FY2020 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
EUDA Health Holdings Ltd revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
EUDA Health Holdings Ltd has earned high returns on invested capital, averaging 15.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
EUDA Health Holdings Ltd capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, EUDA Health Holdings Ltd is modeled at -10.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.47 per share.